Document is current
Any future updates will be listed below
-
Authors
Krumm, Zachary A.
Lloyd, Grace M.
Francis, Connor P.
Nasif, Lith H.
Mitchell, Duane A.
Golde, Todd E.
Giasson, Benoit I. https://orcid.org/0000-0003-2992-4234
Xia, Yuxing
- License Information
-
More Information
Article History
Received: 11 November 2020
Accepted: 4 March 2021
First Online: 29 March 2021
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Todd Golde is a co-founder of Lacerta Therapeutics, Inc. and Andante Biologics Inc. and serves on their scientific advisory boards (SABs). He is on the SAB for Promis Neuroscience, Inc. In the past he has served, ad hoc, on SABs related to neurodegenerative disease programs for Eli Lilly, Novartis, Bristol Myers Squib, Abbvie, Lundbeck, Biogen and Pfizer. He has served on the medical and scientific advisory board for the Alzheimer’s Association. He serves as a scientific advisor and participates in grant reviews for BrightFocus Foundation and the American Federation for Aging Research. He is a co-inventor on multiple patents and patent applications relating to AD therapeutics. Dr. Duane A. Mitchell holds related patents that haven been licensed to iOncologi, Inc.
